Cost-Effectiveness Analysis of Xiyanping Injection (Andrographolide Sulfonate) for Treatment of Adult Community Acquired Pneumonia: A Retrospective, Propensity Score-Matched Cohort Study

Table 3

Characteristics at baseline before PSM: Xiyanping combination versus antiviral.

Variable	Xiyanping combination		Antiviral		P
	N	%	N	%
Sample size	65	22.2%	228	77.8%
Age (y), mean ± SD	46.14±19.71		59.47±18.49		<0.001
Gender
Male	32	49.2%	108	47.4%	0.791
Female	33	50.8%	120	52.6%	0.791
Marriage
Widowed	0	0.0%	2	0.9%	0.450
Married	56	87.5%	211	93.4%	0.125
Single	8	12.5%	11	4.9%	0.029
Divorced or others	0	0.0%	2	0.9%	0.450
Occupation
Peasants	37	57.8%	155	68.0%	0.130
Employment	8	12.5%	22	9.6%	0.507
Unemployment	1	1.6%	5	2.2%	0.753
Retirement	3	4.7%	17	7.5%	0.438
Unknown	9	14.1%	8	3.5%	0.001
Others	6	9.4%	21	9.2%	0.968
Comorbidities
Yes	4	1.8%	9	13.8%	0.446
No	61	93.8%	219	336.9%	0.446
CRP difference	39.39±43.63		35.41±49.32		0.560
Neutrophil proportion difference	76.74±14.66		72.33±11.90		0.049
Neutrophil count difference	6.14±2.85		5.93±3.84		0.672
White blood cell count difference	7.88±3.12		7.88±4.00		0.996